
CLOV • NASDAQ
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
You don't hold CLOV in your mock portfolio yet.
Clover Health remains unprofitable, as indicated by its negative EPS and PE ratio. The current earnings profile suggests ongoing losses with no clear evidence in the provided data of a near-term inflection to sustained profitability. Without improving margins or positive net income, the equity story is still high-risk and heavily execution-dependent.
Despite a modest 1.2% gain over the last month, Clover Health trades below its 200-day moving average, signaling a prevailing downtrend. The very low RSI near 27 suggests the stock is oversold, which can lead to short-term bounces but also reflects persistent selling pressure. Overall, the technical setup is weak, with only a tentative case for a near-term relief rally.
Alternative data for Clover Health is mixed but generally subdued. Website traffic is flat, job postings have declined slightly, and social media followings are growing only marginally. These indicators suggest a stable but not rapidly expanding commercial footprint, with limited evidence of accelerating demand or aggressive growth investment.
Clover Health’s current profile is characterized by ongoing losses, a weak technical setup, and only neutral alternative data signals. While the oversold RSI could support a short-term bounce, the broader risk/reward remains skewed to the downside until there is clearer evidence of improving profitability and stronger growth momentum. Overall, the stock appears more suitable for speculative traders than for fundamentals-driven, long-term investors at this stage.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
Key moves vs recent baseline (last day / last week)
Plain-English summary of the biggest drivers (informational)
Potential risk factors to review
Based on earnings timing, volatility, liquidity and crowd activity. Informational signals only — not investment advice.
Reassess your thesis if any of these occur: